Previous Close | $199.31 |
Intrinsic Value | $22.98 |
Upside potential | -88% |
Data is not available at this time.
Align Technology, Inc. is a global leader in the medical device industry, specializing in innovative orthodontic solutions. The company’s flagship product, Invisalign, is a clear aligner system that has revolutionized teeth straightening, offering a discreet and convenient alternative to traditional braces. Align also provides digital scanning solutions through its iTero intraoral scanners, which enhance treatment planning and patient engagement. The company operates in a highly competitive but growing sector, driven by increasing demand for aesthetic dental treatments and technological advancements in orthodontics. Align’s direct-to-consumer and professional channels, combined with strong brand recognition, position it as a dominant player in the clear aligner market. Its global footprint and continuous R&D investments further solidify its competitive edge, enabling it to cater to diverse patient needs across multiple demographics.
Align Technology reported revenue of $3.99 billion for FY 2024, reflecting steady growth in its core markets. Net income stood at $421.4 million, with diluted EPS of $5.62, indicating robust profitability. Operating cash flow was $738.2 million, demonstrating strong cash generation capabilities. Capital expenditures totaled $115.6 million, highlighting disciplined investment in growth initiatives. The company’s ability to maintain high margins underscores its operational efficiency and pricing power in the orthodontic sector.
Align’s earnings power is supported by its premium product offerings and scalable business model. The company’s return on invested capital remains healthy, driven by high-margin clear aligner sales and recurring revenue from scanner services. With minimal debt and substantial cash reserves, Align is well-positioned to reinvest in innovation and expand its market share without compromising financial stability.
Align Technology maintains a strong balance sheet, with $1.04 billion in cash and equivalents and only $119.3 million in total debt. This low leverage ratio provides significant financial flexibility. The company’s liquidity position is robust, ensuring it can meet short-term obligations and fund strategic initiatives without undue reliance on external financing.
Align has consistently delivered revenue growth, driven by increasing adoption of Invisalign and iTero scanners. The company does not currently pay dividends, opting instead to reinvest profits into R&D and global expansion. This strategy aligns with its focus on long-term growth and market penetration, particularly in emerging markets where demand for orthodontic solutions is rising.
The market values Align Technology at a premium, reflecting its leadership position and growth potential. Investors anticipate sustained revenue expansion, supported by technological innovation and increasing global demand for aesthetic dental treatments. Valuation multiples remain elevated, indicating high expectations for future earnings and market share gains.
Align’s strategic advantages include its strong brand, proprietary technology, and extensive clinical data supporting Invisalign’s efficacy. The company is well-positioned to capitalize on trends toward digital dentistry and personalized orthodontic care. Near-term challenges include competitive pressures and macroeconomic uncertainties, but long-term prospects remain favorable given its innovation pipeline and global growth opportunities.
10-K, Investor Presentations
show cash flow forecast
Fiscal year | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 | 2035 | 2036 | 2037 | 2038 | 2039 | 2040 | 2041 | 2042 | 2043 | 2044 | 2045 | 2046 | 2047 | 2048 | 2049 | |
INCOME STATEMENT | ||||||||||||||||||||||||||
Revenue growth rate, % | NaN | |||||||||||||||||||||||||
Revenue, $ | NaN | |||||||||||||||||||||||||
Variable operating expenses, $m | NaN | |||||||||||||||||||||||||
Fixed operating expenses, $m | NaN | |||||||||||||||||||||||||
Total operating expenses, $m | NaN | |||||||||||||||||||||||||
Operating income, $m | NaN | |||||||||||||||||||||||||
EBITDA, $m | NaN | |||||||||||||||||||||||||
Interest expense (income), $m | NaN | |||||||||||||||||||||||||
Earnings before tax, $m | NaN | |||||||||||||||||||||||||
Tax expense, $m | NaN | |||||||||||||||||||||||||
Net income, $m | NaN | |||||||||||||||||||||||||
BALANCE SHEET | ||||||||||||||||||||||||||
Cash and short-term investments, $m | NaN | |||||||||||||||||||||||||
Total assets, $m | NaN | |||||||||||||||||||||||||
Adjusted assets (=assets-cash), $m | NaN | |||||||||||||||||||||||||
Average production assets, $m | NaN | |||||||||||||||||||||||||
Working capital, $m | NaN | |||||||||||||||||||||||||
Total debt, $m | NaN | |||||||||||||||||||||||||
Total liabilities, $m | NaN | |||||||||||||||||||||||||
Total equity, $m | NaN | |||||||||||||||||||||||||
Debt-to-equity ratio | NaN | |||||||||||||||||||||||||
Adjusted equity ratio | NaN | |||||||||||||||||||||||||
CASH FLOW | ||||||||||||||||||||||||||
Net income, $m | NaN | |||||||||||||||||||||||||
Depreciation, amort., depletion, $m | NaN | |||||||||||||||||||||||||
Funds from operations, $m | NaN | |||||||||||||||||||||||||
Change in working capital, $m | NaN | |||||||||||||||||||||||||
Cash from operations, $m | NaN | |||||||||||||||||||||||||
Maintenance CAPEX, $m | NaN | |||||||||||||||||||||||||
New CAPEX, $m | NaN | |||||||||||||||||||||||||
Total CAPEX, $m | NaN | |||||||||||||||||||||||||
Free cash flow, $m | NaN | |||||||||||||||||||||||||
Issuance/(repurchase) of shares, $m | NaN | |||||||||||||||||||||||||
Retained Cash Flow, $m | NaN | |||||||||||||||||||||||||
Pot'l extraordinary dividend, $m | NaN | |||||||||||||||||||||||||
Cash available for distribution, $m | NaN | |||||||||||||||||||||||||
Discount rate, % | NaN | |||||||||||||||||||||||||
PV of cash for distribution, $m | NaN | |||||||||||||||||||||||||
Current shareholders' claim on cash, % | NaN |